Hudson Bay Capital Management’s Cidara Therapeutics CDTX Stock Holding History

Hudson Bay Capital Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,751	Closed	-$3.48M	–	1421
2025 Q4	$3.48M	Buy	+15,751	New	+$2.55M	0.01%	595

Hudson Bay Capital Management's CDTX Position: Q1 2026 in Review

Hudson Bay Capital Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 15,751 shares — an estimated $3.48M sold.

Hudson Bay Capital Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $3.48M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Hudson Bay Capital Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Hudson Bay Capital Management sold 15,751 Cidara Therapeutics shares in Q1 2026, an estimated $3.48M.
Hudson Bay Capital Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Hudson Bay Capital Management's Cidara Therapeutics position peaked at $3.48M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.